Skip to Main Content

Paper Details

Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial.
J Immunother Cancer
21
2021
Author NameAffiliation
Jes??s Garc??a-DonasHM Hospitales Centro Integral Oncologico Clara Campal
Iain A McNeishInstitute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow
Iain A McNeishBeatson West of Scotland Cancer Centre
Iain A McNeishOvarian Cancer Action Research Centre, Imperial College London
  • 1 - 4

Datasets

Release 1.2